DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol

Neuropharmacology

Volumn 36, Issue 8, 1997, Pages 1109-1114

  Duvauchelle, C L ^a,b,c   Fleming, S M ^a,b   Kornetsky, C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

ICS; Opioid; Self stimulation

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FLUPENTIXOL; MU OPIATE RECEPTOR AGONIST; OPIATE PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; DRUG INFUSION; DRUG MECHANISM; FACILITATION; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD; SELF STIMULATION;

ANIMALS; BRAIN; DOPAMINE ANTAGONISTS; DRUG ANTAGONISM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; FLUPENTHIXOL; INJECTIONS; MALE; NUCLEUS ACCUMBENS; RATS; RATS, INBRED F344; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; REWARD; SELF STIMULATION; SYNAPTIC TRANSMISSION;

EID: 0030834135     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00075-0     Document Type: Article

References (29)

1. Acquas E. and Di Chiara G. (1992) Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. Journal of Neurochemistry 58 (5): 1620-1624.
2. Bain G. T. and Kornetsky C. (1987) Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Science 40: 1119-1125.
3. Bird M. and Kornetsky C. (1986) Naloxone antagonism of the effects of MDMA "ecstasy" on rewarding brain stimulation. The Pharmacologist 28: 150.
4. Churchill L. and Kalivas P. W. (1992) Dopamine depletion produced augmented behavioral responses to mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse 11: 47-57.
5. Dauge V., Rossignol P. and Roques B. P. (1988) Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes. Psychopharmacology 96: 343-352.
6. Di Chiara G. and Imperato A. (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. Journal of Pharmacology and Experimental Therapeutics 244 (3): 1067-1080.
7. Duvauchelle C. L., Fleming S. M. and Kornetsky C. (1996) Involvement of δ and μ receptors in the potentiation of brain-stimulation reward. European Journal of Pharmacology 316: 137-143.
8. Esposito R. and Kornetsky C. (1977) Morphine lowering of self-stimulation thresholds: lack of tolerance with long term administration. Science 195: 189-191.
9. Esposito R. U., Perry W. and Kornetsky C. (1980) Effects of D-amphetamine and naloxone on brain stimulation reward. Psychopharmacology 68: 187-191.
10. Hubner C. B., Bain G. T. and Kornetsky C. (1987) The combined effects of morphine and D-amphetamine on the threshold for brain stimulation reward. Pharmacology, Biochemistry and Behavior 28: 311-315.
11. Izenwasser S. and Kornetsky C. (1989) The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward. Pharmacological and Biochemical Behavior 32: 983-986.
12. Johnson P. I. and Stellar J. R. (1994) Comparison of δ opiate receptor against induced reward and motoreffects between the ventral pallidum and dorsal striatum. Neuropharmacology 33: 1171-1182.
13. Johnson P. I., Stellar J. R. and Paul A. D. (1993) Regional reward differences within the ventral pallidum are revealed by microinjections of a μ opiate receptor agonist. Neuropharmacology 32: 1305-1314.
14. Kalivas P. W., Widerlov E., Stanley D., Breese G. R. and Prange A. (1983) Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. Journal of Pharmacology and Experimental Therapeutics 227: 229-237.
15. Kalivas P. W., Churchill L. and Klitenick M. A. (1993) GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57: 1047-1060.
16. Knapp C. and Kornetsky C. (1989) The effects of amfonelic acid alone and in combination with naloxone on brain-stimulation reward. Pharmacology, Biochemistry and Behavior 32: 977-982.
17. Kornetsky C. and Esposito R. U. (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Federation Proceedings 38: 2473-2476.
18. Kuribara H. (1995) Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. European Journal of Pharmacology 275: 251-258.
19. Mansour A., Khachaturian H., Lewis M. E. and Watson S. J. (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. Journal of Neuroscience 7 (8): 2445-2464.
20. Meyer M. E., McLaurin B. I., Allen M. and Meyer M. E. (1994) Biphasic effects in intraaccumbens mu-opioid peptide agonist DAMGO on locomotor activities. Pharmacology, Biochemistry and Behavior 47 (4): 827-831.
21. Sarkar M., Huston-Lyons D. and Kornetsky C. (1995) Reward-specific blockade of morphine's effect on brain-stimulation reward by pimozide but not SCH23390. Experimental and Clinical Psychopharmacology 3 (2): 118-122.
22. Sesack S. R. and Pickel V. M. (1995) Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Research 672: 261-275.
23. Shippenberg T. S., Bals-Kubik R. and Herz A. (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. Journal of Pharmacology and Experimental Therapeutics 265 (1): 53-59.
24. Spanagel R., Herz A. and Shippenberg T. S. (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. Journal of Neurochemistry 55 (5): 1734-1740.
25. Stinus L., Nadaud D., Deminiere J. M., Jauregui J., Hand T. H. and Le Moal M. (1989) Chronic flupenthixol treatment potentiates the reinforcing properties of peripheral heroin administration. Biological Psychiatry 26: 363-371.
26. Swanson L. W. (1992) Brain Maps: Structure of the Rat Brain (Atlas and Computer Graphics Files). Elsevier, Amsterdam.
27. Toyoshi T., Ukai M. and Kameyama T. (1992) Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice. European Journal of Pharmacology 213: 25-30.
28. Unterwald E. M., Tempel A., Koob G. F. and Zukin R. S. (1989) Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions. Brain Research 505: 111-118.
29. Vaccarino F. J., Mogil J. S. and Stinus L. (1995) Chronic dopamine antagonism facilitates opiate-induced feeding. Journal of Psychiatric Neuroscience 20 (3): 210-214.